{
    "2021-07-02": [
        [
            {
                "time": "",
                "original_text": "制药行业周榜：各板块冷热不均，中药板块迎政策利好一枝独秀",
                "features": {
                    "keywords": [
                        "中药",
                        "政策利好",
                        "板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "复星医药氮氧化物和二氧化硫年排放百吨,通策医疗温室气体排放少",
                "features": {
                    "keywords": [
                        "复星医药",
                        "氮氧化物",
                        "二氧化硫",
                        "通策医疗",
                        "温室气体"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "医疗"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "下一个片仔癀诞生？山西国资入主广誉远，10天大涨 75%",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "山西国资",
                        "广誉远",
                        "大涨"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "突发！“宫廷神药”遭大股东“抛售”，曾被0元收入囊中，如今市值超200亿",
                "features": {
                    "keywords": [
                        "宫廷神药",
                        "大股东",
                        "抛售",
                        "市值"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "广誉远和新晋第一大客户湖南凯信的“合作谜团”",
                "features": {
                    "keywords": [
                        "广誉远",
                        "湖南凯信",
                        "合作谜团"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "这些中成药卖得好",
                "features": {
                    "keywords": [
                        "中成药",
                        "销售"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "落寞的同仁堂：经营业绩停滞 市值不及片仔癀的五分之一 经营问题",
                "features": {
                    "keywords": [
                        "同仁堂",
                        "经营业绩",
                        "停滞",
                        "市值",
                        "片仔癀"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "手握定价权的片仔癀，为什么能卖到 1700 元一粒？",
                "features": {
                    "keywords": [
                        "片仔癀",
                        "定价权",
                        "价格"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "重磅！卫健委发布利好政策 中药板块起飞",
                "features": {
                    "keywords": [
                        "卫健委",
                        "利好政策",
                        "中药板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "迎利好政策，高毅抢筹龙头股大赚超6亿元！业绩持续增长股有这些",
                "features": {
                    "keywords": [
                        "利好政策",
                        "高毅",
                        "龙头股",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中药板块要走出“类白酒大行情”？却有两大隐忧",
                "features": {
                    "keywords": [
                        "中药板块",
                        "类白酒",
                        "大行情",
                        "隐忧"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "中药板块要走出大行情？机构扎堆调研 公募在抢筹 却有两大隐忧",
                "features": {
                    "keywords": [
                        "中药板块",
                        "大行情",
                        "机构调研",
                        "公募",
                        "隐忧"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "制药",
                        "中药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}